BMEA · Biomea Fusion, Inc. · Executive Compensation
$0.60
+0.02 (+2.58%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In connection with the preparation of this Quarterly Report on Form 10-Q for the period ended June 30, 2026, our management has concluded that there is substantial doubt as to whether we can continue as a going concern for the twelve months following the issuance of this Quarterly Report on Form 10-Q. Our ability to continue as a going concern is dependent upon raising capital to maintain current operations and continue research and development efforts. We plan to raise additional capital to fund our operations through public or private equity offerings, debt financings, and/or potential collaborations and license arrangement or other sources. There is no assurance, however, that any additional financing or any revenue-generating collaboration will be available when needed or that we will be able to obtain financing or enter into a collaboration on terms acceptable to us. Based on our current operating plan, we will not be able to continue as a going concern over the next twelve months unless we raise additional capital by other means. These factors raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 5, 2026
Market Cap
$43.50M
Shares
72.48M
Volume · Oct 23
958.01K
Avg daily vol (3M)
2.05M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Michael J.M. Hitchcock | Interim Chief Executive Officer and Principal Executive Officer | $2,569,516 |
| Thomas Butler | Former Chief Executive Officer and Former Chairman of the Board | $661,963 |
| Juan Pablo Frias | Former Chief Medical Officer | $549,037 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Thomas Butler | Former Chief Executive Officer and Former Chairman of the Board | $5,106,387 |
| Franco Valle | Former Chief Financial Officer | $2,078,067 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Juan Pablo Frias | Chief Medical Officer | $3,932,476 |
| Thomas Butler | Former Chief Executive Officer and Former Chairman of the Board | $2,707,310 |
| Franco Valle | Former Chief Financial Officer | $1,299,867 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Thomas Butler | Chief Executive Officer and Chairman of theBoard | $921,140 |
| Franco Valle | Chief Financial Officer | $651,773 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Thomas Butler | Chief Executive Officer and Chairman of the Board | $6,661,207 |
| Franco Valle | Chief Financial Officer | $2,959,193 |
| Ramses Erdtmann | Chief Operating Officer and President | $2,900,049 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Julianne Averill | a member of the Board | Appointed | 2025-07-24 |
| Bihua Chen | a member of the Board and as chairperson of the Compensation Committee of the Board and member of the Nominating and Corporate G | Resigned | 2025-07-24 |
| Rainer (Ramses) Erdtmann | principal accounting officer | Appointed | 2025-03-27 |
| Rainer (Ramses) Erdtmann | principal financial officer | Appointed | 2025-03-27 |
| Thomas Butler | director | Resigned | 2025-03-27 |
| Michael J.M. Hitchcock | interim Chief Executive Officer | Appointed | 2025-03-27 |
| Thomas Butler | Chairman of the Board | Resigned | 2025-03-27 |
| Franco Valle | Chief Financial Officer (principal financial officer and principal accounting officer) | Resigned | 2025-02-28 |
Leadership
- Franco Valle CEO, Chief Accounting Officer
- Michael (Mick) J.M. Hitchcock CEO
- Michael J.M. Hitchcock CEO, Board Member
- Rainer (Ramses) Erdtmann CFO, Chief Accounting Officer
- Ramses Erdtmann COO
- Eric Aguiar Board Member
- Julianne Averill Board Member
- Sumita Ray, J.D. Board Member